Announcement
15 Aug 2022
In August 2022, the EIB provided financing worth EUR 22 million (USD 22 million) to Ryvu Therapeutics.
Source
Sign in to access
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
15 Aug 2022
Revocation date:
No revocation date
Updated: 15 Aug 2022
State loan
In force
The EIB's EUR 22 million (approx. USD 22 million) loan to Ryvu Therapeutics on 15 August 2022 was backed by a guarantee from the European Fund for Strategic Investments (EFSI).
The EFSI is a joint ini...
Sign in to see more
Updated: 15 Aug 2022
State loan
In force
On 15 August 2022, the European Investment Bank (EIB) and Ryvu Therapeutics signed a loan agreement worth EUR 22 million (approx. USD 22 million) for the project 'RYVU (EGFF)' from Poland. The benefic...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.